Pfizer in talks to buy Seagen for likely for more than $30 billion - WSJ
...(Reuters) - Pfizer Inc is in early talks to acquire drugmaker... respond to Reuters request for…
24,545€
2,85%
Echtzeit-Aktienkurs Pfizer Inc.
Bid:
Ask:
Nachrichten zur Pfizer Inc. Aktie
Pfizer in talks to buy Seagen for likely for more than $30 bln - WSJ
...Feb 26 (Reuters) - Pfizer Inc is in early talks
to acquire drugmaker... respond to Reuters request for a comment.
Seagen was…
Pfizer In Early Talks To Buy Cancer-Focused Seagen: WSJ
read more...…
Pfizer eyes takeover of biotech Seagen, at value of more than $30 billion
Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…
BRIEF-Pfizer In Early-Stage Talks To Acquire Seagen - WSJ
...Feb 26 (Reuters) -
* PFIZER IN EARLY-STAGE TALKS TO ACQUIRE SEAGEN......…
Pfizer in Early-Stage Talks to Acquire Seagen
Pfizer Inc. is in talks to acquire biotech Seagen Inc, according to people familiar with the matter, the latest potential…
Leftists Furious As Woody Harrelson Sneaks Covid Vaccine Mandate Joke Onto SNL
Leftists Furious As Woody Harrelson Sneaks Covid Vaccine Mandate Joke Onto SNL
…
NewsGuard Misinfo Watchdog: Contracts With DOD, WHO, Pfizer, Microsoft, & AFT
NewsGuard Misinfo Watchdog: Contracts With DOD, WHO, Pfizer, Microsoft, & AFT
…
FDA says Guillain-Barre syndrome is possible risk of Pfizers RSV vaccine for older adults
The FDA sees a potential risk and has asked Pfizer to conduct a safety study on Guillain-Barre after a potential…
Pfizer, BioNTech seek FDA full approval for Omicron shot
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pfizer to face FDA AdCom meeting for full approval of COVID-19 pill
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Natural Immunity Better Than COVID Vaccination Against Omicron: CDC Study Admits
Natural Immunity Better Than COVID Vaccination Against Omicron: CDC Study Admits
…
Pfizer/BioNTech Seek Expanded Approval For Its Updated COVID-19 Shot As Primary Series Vaccination
read more...…
Pfizer/BioNTech apply for full approval of updated COVID vaccine
...(Reuters) - Pfizer Inc and BioNTech SE said on Friday they filed......…
Form 10-K PFIZER INC For: Dec 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pharma Giant Pfizer Looks Strong for Investors, Despite COVID Sales Drop
The company is doubling down on its vaccine success....…
Idaho Lawmakers Seek To Criminalize Injecting Of mRNA COVID-19 Vaccines
Idaho Lawmakers Seek To Criminalize Injecting Of mRNA COVID-19 Vaccines
…
Pfizer looks set to be the first to deliver a long-awaited RSV drug
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
GSK, Pfizer joint venture gets EU marketing approval for HIV treatment
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
Pfizer: FDA Grants Priority Review For BLA For Elranatamab
NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) announced the FDA has granted Priority Review for the companys Biologics License…
Pfizer Gets FDA Priority Review for Elranatamab in Multiple Myeloma >PFE
Pfizer Gets FDA Priority Review for Elranatamab in Multiple Myeloma >PFE...…
Pfizer, GSK Are Competing to Make the Best RSV Vaccine
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pfizer: Zulassungsantrag für den RSV-Impfstoffkandidaten akzeptiert - Aktienanalyse
Kulmbach (www.aktiencheck.de) - Pfizer-Aktienanalyse von "Der Aktionär":
Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Pfizer Inc. (ISIN: US7170811035,…
BioNTech-Partner Pfizer: RSV-Impfstoff auf der Zielgeraden – Termin vormerken
Pfizer kommt bei seinem RSV-Impfstoffkandidaten RSVpreF (PF-06928316) voran. Wie der US-Pharmakonzern mitgeteilt hat, hat die amerikanische Zulassungsbehörde FDA den Zulassungsantrag…
Pfizer looks set to be the first deliver a long-awaited RSV drug
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pfizer RSV vaccine that protects infants could receive FDA approval this summer
The single-dose RSV vaccine developed by Pfizer is administered to expectant mothers in the late second-to-third trimester of their pregnancy....…
Lung Cancer Drugs Global Market Report 2023
NEW YORK, Feb. 21, 2023 /PRNewswire/ -- Major players in the lung cancer market are Bristol-Myers Squibb Company, Merck &…
First RSV Vaccine For Kids—Given To Pregnant Moms—Could Arrive Months Early As FDA Fast-Tracks Review
If approved, Pfizers RSV shot for pregnant people could be the first on the market and protect infants from complications…
Pfizer: FDA Accepts For Review BLA For Respiratory Syncytial Virus Vaccine Candidate
NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) announced the FDA has accepted for review a Biologics License Application for…
Pfizer Gets FDA Priority Review of Respiratory Syncytial Virus Maternal Vaccine Candidate >PFE
Pfizer Gets FDA Priority Review of Respiratory Syncytial Virus Maternal Vaccine Candidate >PFE...…
Pfizer Knowingly Allowed Dangerous Components In Its Vaccines
Pfizer Knowingly Allowed Dangerous Components In Its Vaccines
Authored…
Antacids Global Market Report 2023
NEW YORK, Feb. 20, 2023 /PRNewswire/ -- Major players in the antacids market are GlaxoSmithKline plc, Pfizer Inc., Bayer AG,…
Antiglaucoma Drugs Global Market Report 2023
NEW YORK, Feb. 20, 2023 /PRNewswire/ -- Major players in the antiglaucoma drugs market are Aerie Pharmaceuticals, Inc., Allergan, Novartis…
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what…
Bladder Cancer Drugs Global Market Report 2023
NEW YORK, Feb. 17, 2023 /PRNewswire/ --Major players in the bladder cancer drugs market are Pfizer, Celgene Corporation, Eli Lilly,…
Pfizer Shuts Trial Sites for Lyme Disease Jab After Standards Breaches
The company and its partner Valneva have removed about half of the participants from the Vaccine program, citing violations of…
UPDATE 2-Pfizer, Valneva to stop testing Lyme disease vaccine in some U.S. patients
... (Reuters) - Drugmaker Pfizer Inc and
Frances Valneva will stop testing......…
Pfizer, Valneva removes ~50% participants in Lyme disease vaccine trial on violation woes
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Null-Toleranz? Europaparlament im Korruptionssumpf
EU-Parlamentspräsidentin will offiziell mehr Transparenz. Das gilt aber offenbar nicht für die Pfizer-SMS von der Leyens oder Metsolas Angaben zu…
Valneva, Pfizer to Discontinue Some Trials for Lyme Disease Vaccine
Valneva, Pfizer to Discontinue Some Trials for Lyme Disease Vaccine...…
Pfizer and Valneva discontinue some trials on vaccine against Lyme disease
...PARIS (Reuters) - U.S. drugs giant Pfizer and vaccine company......…
Pfizer and Valneva Issue Update on Phase 3 Clinical Trial Evaluating Lyme Disease Vaccine Candidate VLA15
New York & Saint-Herblain (France), February 17, 2023 – Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris:…
Klage gegen EU-Kommission: Was steht in den SMS von der Leyens an Pfizer?
New York Times versucht über ein EU-Gericht herauszufinden, wie die "persönliche Diplomatie" zwischen der EU-Kommissionspräsidentin und dem Chef des US-Pharmakonzerns…
Antiobesity Global Market Report 2023
NEW YORK, Feb. 16, 2023 /PRNewswire/ -- Major players in the anti-obesity market are F. Hoffmann-La Roche AG, GlaxoSmithKline PLC,…
Pfizer/ BioNTech, Moderna set for 2024 trial in COVID vaccine patent dispute
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pfizer Reports Positive Data From Phase 3 Trial Of Talzenna/Xtandi Combo
NEW YORK CITY (dpa-AFX) - Pfizer (PFE) Thursday reported positive results from the Phase 3 TALAPRO-2 study of Talzenna, an…
Drug makers are looking to drive diversity in clinical trials
Bertha Coombs reports drug makers are trying to up the ante on diversity in clinical trials. Eli Lilly's mobile lab…
Protein Inhibitors Global Market Report 2023
NEW YORK, Feb. 16, 2023 /PRNewswire/ -- Major players in the protein inhibitors market are Bayer AG, Astra Zeneca, Roche,…
Cervical Cancer Drugs Global Market Report 2023
NEW YORK, Feb. 16, 2023 /PRNewswire/ -- Major players in the cervical cancer drugs market are F. Hoffmann-La Roche Ltd,…
Pfizer granted priority review for Talzenna, Xtandi combination for prostate cancer
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…